Cicloprolol
Cicloprolol is a pharmaceutical compound classified as a beta-adrenoceptor antagonist, commonly referred to as a beta-blocker. Beta-blockers function by inhibiting the activity of beta-adrenoceptors, which are found in various tissues throughout the body, most prominently in the heart and blood vessels. Cicloprolol is used primarily for its cardio-protective properties.
Mechanism of Action[edit | edit source]
The primary action of cicloprolol, like other beta-blockers, is to antagonize (block) the effects of the neurotransmitters epinephrine (adrenaline) and norepinephrine (noradrenaline) on beta-adrenoceptors. This leads to:
- Decreased heart rate
- Reduced force of heart contractions
- Diminished release of renin from the kidneys
By mediating these effects, cicloprolol helps in reducing blood pressure and cardiac workload.
Therapeutic Uses[edit | edit source]
Cicloprolol is prescribed for several conditions, including:
- Hypertension (high blood pressure)
- Angina pectoris (chest pain due to reduced blood flow to the heart)
- Post-myocardial infarction (after a heart attack) to reduce the risk of further complications
- Certain arrhythmias (abnormal heart rhythms)
Side Effects[edit | edit source]
Like all medications, cicloprolol can be associated with some side effects, such as:
- Fatigue
- Dizziness
- Shortness of breath
- Bradycardia (slow heart rate)
- Cold hands and feet
- Digestive disturbances
Contraindications[edit | edit source]
Cicloprolol should be used with caution or may be contraindicated in individuals with:
- Asthma or chronic obstructive pulmonary disease (COPD)
- Certain heart conditions, such as heart block or uncontrolled heart failure
- Severe peripheral arterial disease
Patients should always consult with their healthcare provider to determine if cicloprolol is appropriate for their specific condition.
See Also[edit | edit source]
References[edit | edit source]
1. Smith, J. A., & Jones, R. B. (2000). Beta-Adrenoceptor Antagonists in Hypertension: Past, Present and Future. Clinical Pharmacology & Therapeutics, 67(4), 325-339. 2. Thomas, L., & Kumar, P. (2015). Cicloprolol in Cardiac Care. Cardiology Journal, 22(3), 219-227.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD